What will the current COVID-19 vaccine candidates mean for Australians with autoimmune conditions? Can we take them? When will we get them?
Ixekizumab (Taltz®) is a new treatment option for Australians with ankylosing spondylitis - a chronic form of arthritis that affects the spine and pelvis.
It can be a big adjustment to give yourself injections. These tips can make the process less scary.
If you are living with rheumatoid or other inflammatory arthritis, systemic lupus erythematosus and other autoimmune diseases, please take a moment to read this important information from the Australian Rheumatology Association (ARA) regarding COVID-19.
Do you use a biologic medication for your inflammatory arthritis? Do you know about biosimilars? Discover the basics as part of Biosimilar Awareness Week.
Axial spondyloarthritis (including ankylosing spondylitis) is a common form of arthritis, yet most Australians haven’t heard of it. CreakyJoints Australia would like to help change that.
Upadacitinib (Rinvoq®) is a new treatment option now available for adults with moderate to severe RA who can't tolerate methotrexate or don't respond sufficiently to it.
What should you do if you can’t access Plaquenil? Are you at risk of COVID-19 exposure if you have a biologic infusion in a hospital? We’ve got the answers you’ve been seeking.
Are you an Australian with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn’s Disease or ulcerative colitis?
Do you regularly attend face-to-face health appointments such as medication reviews, physiotherapy and blood tests? Should you still go during the lockdown?